Goldman Sachs
SQZ

Goldman Sachs’s SQZ Biotechnologies Company SQZ Stock Holding History

Goldman Sachs’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15,896
Closed -$4.29K – 6077
2023
Q2 		$4.29K Buy
15,896
+1,012
+7% +$574 ﹤0.01% 5640
2023
Q1 		$8.34K Sell
14,884
-3,316
-18% -$2.44K ﹤0.01% 5759
2022
Q4 		$13.5K Sell
18,200
-7,595
-29% -$16.6K ﹤0.01% 5731
2022
Q3 		$58K Sell
25,795
-22,231
-46% -$66.7K ﹤0.01% 5785
2022
Q2 		$152K Buy
48,026
+18,634
+63% +$67K ﹤0.01% 5733
2022
Q1 		$141K Sell
29,392
-14,047
-32% -$89.2K ﹤0.01% 5994
2021
Q4 		$388K Buy
43,439
+8,449
+24% +$104K ﹤0.01% 5530
2021
Q3 		$505K Buy
34,990
+1,014
+3% +$13.7K ﹤0.01% 5183
2021
Q2 		$491K Buy
33,976
+8,545
+34% +$112K ﹤0.01% 5236
2021
Q1 		$348K Buy
25,431
+5,197
+26% +$106K ﹤0.01% 5342
2020
Q4 		$586K Buy
+20,234
New +$516K ﹤0.01% 4509

Other funds holding SQZ

AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Goldman Sachs's SQZ Position: Q3 2023 in Review

Goldman Sachs sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 15,896 shares — an estimated $4.29K sold.

Goldman Sachs first reported a position in SQZ in Q4 2020 and held it in 11 quarters. The position peaked at $586K in Q4 2020. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

  • Goldman Sachs reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
  • Goldman Sachs sold 15,896 SQZ Biotechnologies Company shares in Q3 2023, an estimated $4.29K.
  • Goldman Sachs first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 11 quarters.
  • Goldman Sachs's SQZ Biotechnologies Company position peaked at $586K in Q4 2020.
  • 5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on Goldman Sachs's 13F filing for Q3 2023, filed 14 Nov 2023.